Integration of Spark into Roche Group Set, Hemophilia Gene Therapy Program Continues
Integration of Spark into Roche Group Set, Hemophilia Gene Therapy Program Continues
In a May 27th letter to the hemophilia community, it was confirmed that Spark Therapeutics has been fully integrated into the Roche Group.